加强胆固醇管理 迎接冠心病拐点——中国血脂管理指南(2023)解读  

Strengthen lipid management, meet the inflection point of coronary heart disease: to decipher Chinese guidelines for lipid management(2023)

作　　者：黄坤 程翔[1] 廖玉华[1] HUANG Kun;CHENG Xiang;LIAO Yuhua(Department of Cardiology,Union Hospital,Tongji Medical College,Huazhong University of Science and Technology,Wuhan,430022,China)

机构地区：[1]华中科技大学同济医学院附属协和医院心内科,武汉430022

出　　处：《临床心血管病杂志》2023年第5期340-341,共2页Journal of Clinical Cardiology

摘　　要：《中国血脂管理指南(2023年)》于2023年3月重磅发布,引发了广泛关注。与《中国成人血脂异常防治指南(2016年)》相比,新指南在诸多方面做了更新,其中强化降脂和联合用药两个方面值得关注。新指南的更新为临床进一步降低血脂异常患者心血管事件风险提供了可靠指导。Chinese guidelines for lipid management(2023)were released in March this year,which attracted widespread attention.Compared with the"Guidelines for the Prevention and Treatment of Dyslipidemia in Chinese Adults(2016)",the new guidelines have been updated in many aspects,among which"intensive lipid reduction"and"combination medication"are worthy of attention.The updated guidelines provide reliable guidance for further reducing the risk of cardiovascular events in patients with dyslipidemia.

关 键 词：血脂管理 中国血脂管理指南 

分 类 号：R543[医药卫生—心血管疾病]